Thursday, March 30, 2023
  • About Us
  • Contact Us
Parliamentobserver
  • Ecology
  • Economy
  • Healthcare
  • Politics
  • Education
  • Business
  • Login
No Result
View All Result
Parliamentobserver
Home Economy

Did We Need Operation Warp Speed?

Dennis Rogers by Dennis Rogers
September 29, 2022
in Economy
0
Did We Need Operation Warp Speed?
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

Reprinted from the Independent Institute

Over two years after the World Health Organization declared Covid-19 a global pandemic, it seems the end is quickly approaching. Unfortunately, the end of the pandemic appears to be the start of an endemic. Even Dr. Anthony Fauci has admitted, “we’ve only eradicated one infectious disease in man, and that’s smallpox. That’s not going to happen with this virus.”

Related posts

Biden could reduce inflation, mitigate a recession, and strengthen democracy with a new EU-US trade agreement

Biden could reduce inflation, mitigate a recession, and strengthen democracy with a new EU-US trade agreement

September 29, 2022
Recent trends in global value chains and beyond

Recent trends in global value chains and beyond

September 29, 2022

Endemic viruses can take a variety of paths as time passes and they continue to mutate. Thankfully, Covid-19’s variations seem to be following a pattern of becoming more infectious but less harmful. How to address future variants, develop new medical goods, and provide care while we “learn to live with Covid” remains a critical question.

Admitting Covid-19 is likely endemic also raises challenging questions about the many futile attempts to stop Covid-19 from spreading by using draconian measures to curtail personal and economic freedoms. Were the costs worth it? And how much did we benefit now that Covid is unlikely to disappear?

We can extend the same skepticism and criticism to Operation Warp Speed (OWS).

As Covid-19 spread seemingly uncontrollably through the country in early 2020, it seemed the only ways to end the pandemic were through herd immunity, prolonging lockdown-like measures, or mass vaccination. Herd immunity was a deadly (literally and politically) strategy. Lockdowns and many other preventative measures provided no clear ending. But developing a vaccine for a novel virus required pathbreaking and unprecedented advancement in medical science in a short time.

Hoping to beat the odds, President Trump launched OWS on May 15th, 2020. The ambitious effort created a public-private partnership between selected drug developers allied with five federal agencies and provided a “blank check” of federal funding.

On December 11th, 2020, the Food and Drug Administration authorized the first Covid-19 vaccine for emergency use in the US. By February 2021, the US had three authorized Covid-19 vaccines. OWS was hailed as “a triumph of public health policy” and a “new model for industrial policy.”

Is it? Plenty of evidence suggests otherwise.

Pfizer, which developed the first authorized Covid-19 vaccine, purposefully used its own laboratories and equipment instead of those provided by OWS. Pfizer CEO Albert Bourla explained, “Our vaccine timing [and development] had nothing to do with politics.” Federal funding provided through OWS for Pfizer to develop the vaccine was about $2 billion, less than 10 percent of the company’s average annual R&D expenditures. Pfizer also refused to use OWS’s designated partner to distribute the vaccine.

As an Intelligencer article highlights, Moderna’s vaccine was fully developed on January 13, 2020—about a week before Covid-19 reached the US. Thus, as the article’s title reads, “We had the vaccine the entire time,” suggesting OWS was unnecessary to develop a Covid-19 vaccine.

After failing to become a finalist in OWS, AstraZeneca began vaccinating patients in the UK in early January 2020. Its vaccine later became one of the most popular Covid-19 vaccines globally. Further, over 100 other Covid-19 vaccines were in development while OWS was underway. Many of these were privately funded.

Considering these facts, it’s hard to give OWS significant credit for bringing us the vaccine.

Challenging and questioning OWS’s effectiveness is more critical now than ever because an endemic Covid-19 requires an innovative approach to address future variants and rising cases. Sadly, as I’ve written before, OWS is likely now preventing additional vaccines and treatments from reaching the market as Covid-19 continues to mutate.

By selecting a handful of drug producers to have expedited approval processes, other vaccine producers cannot compete by developing new products to treat newer Covid-19 variants better. Consequently, patients hoping to protect themselves against new variants continue to receive boosters (sometimes four) while newer and potentially better-suited vaccines wait idly for authorization.

The only way to prepare for endemic Covid-19 is to critically assess what went right and what went wrong during the pandemic. OWS’s efforts to develop Covid-19 vaccines are often considered the crowning achievement of what went right. Unfortunately, I fear its benefits are exaggerated, and its costs are just beginning.

Previous Post

Decriminalizing Cannabis Won’t Stop the Black Market

Next Post

Supply Disturbances Do Not Explain High Inflation

Next Post
Supply Disturbances Do Not Explain High Inflation

Supply Disturbances Do Not Explain High Inflation

RECOMMENDED NEWS

Another Dead Politician

Another Dead Politician

9 months ago
The EU’s experimental approach in overhauling competition rules

The EU’s experimental approach in overhauling competition rules

12 months ago
The WHO Is Developing an International Vaccine Passport

The WHO Is Developing an International Vaccine Passport

1 year ago
Lions and Badgers and Bears: The Team behind Sugarloaf’s Amazing Wildlife Footage

Lions and Badgers and Bears: The Team behind Sugarloaf’s Amazing Wildlife Footage

1 year ago

BROWSE BY CATEGORIES

  • Business
  • Ecology
  • Economy
  • Education
  • Healthcare
  • Politics

POPULAR NEWS

  • Klaus Schwab – The Most Dangerous Man in the World

    0 shares
    Share 0 Tweet 0
  • Dr. Robert Malone v WEF

    0 shares
    Share 0 Tweet 0
  • Ukraine Adopts WEF Proposals

    0 shares
    Share 0 Tweet 0
  • Trudeau’s Approval Rating Hits 12-Month Low

    0 shares
    Share 0 Tweet 0
  • Trudeau Backs Down After Banks Scream about Massive Withdrawals

    0 shares
    Share 0 Tweet 0
Parliamentobserver

We bring you latest news about ecology, economy, healthcare, politics, education, business.

Recent News

  • Supporting Ukrainian Economy: #SpendWithUkraine Initiative Launched by Ukrainian Brands
  • Starting Up: A Look at the Most Interesting Websites for Entrepreneurs and Startups
  • The Role of Healthcare Advertising in Shaping Economic and Political Decisions

Category

  • Business
  • Ecology
  • Economy
  • Education
  • Healthcare
  • Politics

Recent News

Supporting Ukrainian Economy: #SpendWithUkraine Initiative Launched by Ukrainian Brands

Supporting Ukrainian Economy: #SpendWithUkraine Initiative Launched by Ukrainian Brands

February 6, 2023
Starting Up: A Look at the Most Interesting Websites for Entrepreneurs and Startups

Starting Up: A Look at the Most Interesting Websites for Entrepreneurs and Startups

January 18, 2023
  • About Us
  • Contact Us

© 2022 parliamentobserver.com Submit news release

No Result
View All Result
  • Ecology
  • Economy
  • Healthcare
  • Politics
  • Education
  • Business

© 2022 parliamentobserver.com Submit news release

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In